Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial import inner membrane translocase subunit TIM50 (TIMM50) is a core component of the TIM23 translocase complex, essential for protein import across the mitochondrial inner membrane in eukaryotic cells. Acting as the receptor subunit on the matrix side, TIM50 recognizes targeting presequences of mitochondrial precursor proteins, facilitating their transfer from the TOM complex in the outer membrane through to the matrix or inner membrane. TIMM50's activity is critical for mitochondrial function, bioenergetics, and programmed cell death (apoptosis) pathways. Pathogenic variants in TIMM50 cause a spectrum of mitochondrial disorders, including epilepsy, intellectual disability, and 3-methylglutaconic aciduria. Dysregulation of TIMM50 expression has been linked to cancer proliferation and cardiac hypertrophy.
Antiepileptic drugs act on neural excitability to control seizures but do not directly target TIMM50; treatments address symptoms from TIMM50 dysfunction, not the protein itself. No known direct pharmacological inhibitors or activators of TIMM50 are established.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial import inner membrane translocase subunit TIM50 (TIMM50).